CTLA4 and posterior cortical atrophy: Notably, the PCa patients in cluster C2 were more sensitive to CTLA-4 inhibitors alone (p = 5.3e-3), PD-1 inhibitors alone (p = 4.3e-4), or no immune checkpoint inhibitors than were those in cluster C1 (p = 8.8e-3).